TB VaccineThis page contains recent news articles, when available, and an overview of TB Vaccine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.
News: TB Vaccine
Providence Business NewsTB Vaccine and Therapy Foundation Visionary Architect - Carol Nacy Ph.D., CEO Sequella Inc. Founder Sequella Foundation (now Aeras Global TB Vaccine ...
RE: "TB Vaccine in the pipeline" - Nov 9, 2009
Harare TribuneWe were delighted to see that TB vaccine work received attention in your paper, including mentioning some of the work which we are involved in. ...
Crucell Announces Third Quarter 2009 Results - Nov 4, 2009
CNNMoney.com (press release)Phase I: The US Phase I trial in healthy adults not previously immunized with Bacille Calmette-Guérin (BCG), the traditional TB vaccine, has been completed ...
Jack - Bovine tuberculosis - Oct 29, 2009
DeHavilland (press release) (subscription)Select Committee Michael Jack asked if diseased badgers would be killed if they were seen to be carrying TB when they were being given a TB vaccine. ...
Drew - TB Vaccinations and International Research - Oct 27, 2009
DeHavilland (press release) (subscription)The majority of DEFRA's TB vaccine research programme is led by researchers at the Veterinary Laboratories Agency, who collaborate with researchers in both ...
Alexandra Holzer: Woman in the Paranormal - Nov 7, 2009
Tucson Citizen...hoping and praying they find a cure to revive the pancreas. There are talks about using the thirty-year old TB vaccine as it has many uses so we're hopeful.
With $17M Brooklyn Lab, IAVI Eyes Progress - Dec 1, 2008
BioRegion News,Also, we’re in discussions with Aeras [Global TB Vaccine Foundation in Rockville, Md. — Ed.], which is developing vaccines for TB.
Report: US Funding For Research On Neglected Infectious Diseases ... - Dec 19, 2008
Medical News Today (press release),...which continue to kill millions of people worldwide each year," Peg Willingham, Senior Director, External Affairs, Aeras Global TB Vaccine Foundation,
HEALTH SCENE - Dec 6, 2008
Tri Valley Herald,University School of Medicine are seeking volunteers for a study that will look at Type 2 diabetes and the body's immune response to the TB vaccine.
New Vaccine Candidate May Better Protect HIV Positive People from TB - Oct 24, 2008
Voice of AmericaHe explains why a TB vaccine specifically targeted for HIV-positive people was engineered. "The current vaccine is not recommended for HIV-positive people
Cork babies to get routine TB vaccine after 36-year gap - Nov 2, 2008
Irish Times,BABIES BORN in Cork are finally receiving the routine BCG vaccination against TB after a 36-year gap in the service. The vaccination is a routine part of
Novel TB Vaccine May Be Safer for HIV-Infected Patients - Oct 24, 2008
MedPage Today,By Crystal Phend, Staff Writer, MedPage Today LOS ANGELES, Oct. 24 -- An experimental tuberculosis vaccine with limited ability to replicate may be safer
Crucell Announces Third Quarter 2008 Results - Nov 10, 2008
MarketWatchCrucell and Aeras, the Global TB Vaccine Foundation, announced two important advances in its collaborative tuberculosis (TB) vaccine program.
Get a Deep Insight into the Vaccine Technologies and Global Markets - Nov 13, 2008
MarketWatchStudy: The Safety and Immunogenicity of a TB Vaccine; MVA85A in Healthy Volunteers Who Are Infected with HIV 5. Study: Screening of Healthy Volunteers for
Ground-breaking, lifesaving TB vaccine a step closer - Oct 28, 2008
Vaccine Rx (press release),The Aeras Global TB Vaccine Foundation, which was founded to develop new, cost-effective TB vaccines for use in the developing world, has licensed a
Parents in call for TB vaccine - Nov 6, 2008
Stoke & Staffordshire,PARENTS are calling for vaccinations and wider screening after a school staff member was diagnosed with tuberculosis. Clough Hall Technology School,
Now, a safer, more effective TB vaccine for HIV-positive people - Nov 1, 2008
Entertainment and Showbiz!,Scientists at University of California, Los Angeles (UCLA), have developed a new vaccine for tuberculosis (TB), which they claim is safer and more effective
TB vaccine for Aids patients - Oct 28, 2008
Health24.com,A vaccine that protects people with HIV/Aids from being co-infected with tuberculosis may be available in the near future as results of a TB vaccine trial
Oxford Tech-Transfer Arm Licenses Bacterial Meningitis Vaccine ... - Nov 12, 2008
Biotech Transfer Week,...the Oxford-Emergent Tuberculosis Consortium to further develop a TB vaccine candidate originally discovered by Oxford researchers (see BTW, 7/30/2008).
New Vaccine Reduces TB Incidence By 37% Among HIV-Positive People ... - Oct 24, 2008
Medical News Today (press release),All of the study participants previously received the Bacille-Calmette Guerin TB vaccine, and 70% of the study participants were women.
The Union Announces A Successful Trial Of A TB Candidate Vaccine ... - Oct 27, 2008
Medical News Today (press release),...resource-limited areas of the world, our research group was focused on developing an improved TB vaccine specifically for patients with HIV infection.
New hope for TB - Oct 28, 2008
Mail & Guardian Online,Speaking at an international Aids conference the health minister said: "The TB vaccine was invented before the car. The diagnosis of TB has a similar
Emergent BioSolutions Reports Financial Results for Third Quarter ... - Nov 6, 2008
MarketWatchFormed joint venture with the University of Oxford to develop an advanced tuberculosis vaccine, with funding from Wellcome Trust and Aeras Global TB Vaccine
Now, a safer, more effective TB vaccine for HIV-positive people - Oct 24, 2008
DailyIndia.com,Washington, Oct 24: Scientists at University of California, Los Angeles (UCLA), have developed a new vaccine for tuberculosis (TB), which they claim is
Safer, more potent TB shot for HIV-positive developed - Oct 24, 2008
Newstrack India,Washington, Oct 24 (IANS) A new TB vaccine developed for HIV-positive people has been found to be safer and more potent than the current shots in
Daily HIV/Aids Report - Oct 24, 2008
AllAfrica.com,All of the study participants previously received the Bacille-Calmette Guerin TB vaccine, and 70% of the study participants were women.
Funding helps continue TB programmes - Sep 10, 2008
Stuff.co.nz,AgResearch section manager for animal health, Dr Wayne Hein, said the main goal of the research was to produce an improved tuberculosis (TB) vaccine that
Germans test first new TB vaccine for 80 years - Sep 11, 2008
Earthtimes (press release),Berlin - Amid worldwide fears that tuberculosis is adapting to thwart existing drugs, Germany began human testing this week of what is described as the
Not-for-profit group gets new funding for TB vaccine research - Sep 9, 2008
TropIKA,IDRI has received several other grants and contracts from NIAID to support its TB vaccine effort. A team of more than 30 researchers at IDRI is dedicated to
No date from HSE on clearing TB vaccine backlog - Aug 29, 2008
IrishExaminer.com,By Noel Baker THE Health Service Executive has said it does not know when the backlog of families seeking vaccinations for TB will be cleared.
Tuberculosis profile rising - Sep 22, 2008
TropIKA,A TB vaccine phase 1 trial (ie clinical safety trial on volunteers) has recently begun in Germany. Vakzine Projekt Management GmbH have used genetic
Infectious Disease Research Institute receives $6.3 million NIAID ... - Aug 28, 2008
News-Medical.net,The four-year grant will enable IDRI to evaluate adjuvant formulations for a TB vaccine and develop manufacturing processes for testing in clinical trials.
No evidence of TB spread at Denver financial firm - Sep 3, 2008
Rocky Mountain News,While there is no reliable TB vaccine, improvements in air quality and living conditions have put a dent in US TB rates. The TB rate declined 4.2 percent
Current Comment - Sep 5, 2008
America Magazine (subscription),Currently, the TB vaccine is the most widely used vaccine in the world. Called BCG, it is a live vaccine injected each year into 100 million children.
HEALTH SCENE - Sep 20, 2008
Inside Bay Area,University School of Medicine are seeking volunteers for a study that will look at Type 2 diabetes and the body's immune response to the TB vaccine.
New TB vaccine enters clinical trial in Germany - Sep 12, 2008
Fresh News,By ANI on Friday, September 12, 2008 A promising live vaccine against tuberculosis has begun safety testing on volunteers in the first phase of clinical
Health Scene Calendar - Sep 19, 2008
RedOrbit,University School of Medicine are seeking volunteers for a study that will look at Type 2 diabetes and the body's immune response to the TB vaccine.
Get a Deep Insight into the World Human Vaccines Market - Sep 18, 2008
RedOrbit,Major Issues to be addressed in the TB Vaccine Market II-16 Table 3: TB Vaccines Market Worldwide: Annual Sales for 2000-2005 (In US$ Million) (includes
Bovine TB vaccine planned after cull of badgers ruled out - 13 Jul 2008
Darlington and Stockton Times,ENVIRONMENT Secretary Hilary Benn this week announced a £20m plan to develop a vaccine to tackle Bovine TB. The three-year programme aims to develop cattle
Tuberculosis this week (July 7-13) - 13 Jul 2008
Merinews,The World Health Organisation (WHO)'s initiative for vaccine research had earlier sponsored three meetings to discuss assay harmonisation for new TB vaccine
Defra admits that only half of £20m TB vaccine funding is new money - Jul 10, 2008
Farmers Guardian,By Alistair Driver DEFRA has admitted that only half of the money Hilary Benn said was being ploughed into developing TB vaccines over the next three years
Bovine TB vaccination will not be effective in badgers for next 12 ... - Jul 11, 2008
FarmersWeekly,DEFRA secretary Hilary Benn announced on Monday (7 July) he would make £20m available to develop a TB vaccine over the next three years.
More cash for TB vaccine offers lifeline for badgers - Jul 4, 2008
Times Online,Extra funds to speed up the development of a vaccine to control bovine TB in badgers and cattle will be announced by the Government next week.
Gates Foundation to back malaria, TB vaccine research in India - Jul 2, 2008
Mangalorean.com,Washington, July 3 (IANS) Microsoft founder Bill Gates has responded positively to Indian Health Minister Anbumani Ramadoss' request to support research
Anti-TB Drug Fails To Benefit HIV-Exposed Infants - Jul 11, 2008
eMaxHealth.com,...for 96 weeks beginning at 3 to 4 months of age and at least 90 days after receiving Bacille Calmette-Guerin (BCG) vaccination, the standard TB vaccine.
Crawling the Web: Morbidity/Mortality - Jul 2, 2008
Scientist Live,T cell immunity is critical for protection; therefore, the current TB vaccine, bacille Calmette-Guérin (BCG), and most new vaccines under development aim to
Earthlog - Unfair to farmers - who cares if you’re an urban MP? - Jul 10, 2008
Telegraph.co.uk,Badger culling, coupled with the development of a TB vaccine and rigorous cattle testing, could help to solve an £80 million a year problem, as an all-party
$40 million fund to finance medical breakthroughs - Jul 2, 2008
Rocky Mountain News,Waring came from the east coast to Colorado Springs to be treated by renowned tuberculosis specialist Dr. Gerald Webb, who was looking for a TB vaccine.
Kenya: Hospitals Now Run Out of TB Vaccine - Apr 30, 2008
AllAfrica.com,AN acute shortage of a TB vaccine has put the lives of more than 100000 newborn babies at risk. Babies born in the past month have not been immunised
Experts say science is still a white, male world - May 24, 2008
The Times,The Aeras Global TB Vaccine Foundation president and CEO, Dr Jerald Sadoff, said: “We are working to develop and test new TB vaccines not just in Africa,
Crucell Announces First Quarter 2008 Results - May 12, 2008
CNNMoney.comCrucell, the Aeras Global TB Vaccine Foundation and the South African Tuberculosis Vaccine Initiative (SATVI) present encouraging preliminary results from
Kenya Launches Campaign To Increase TB Screening Among HIV ... - May 9, 2008
Kaiser network.org,According to Nyikal, Kenya has received a shipment of 800000 doses of the BCG TB vaccine. A recent government shortage put more than 200000 infants at risk
FDA inspection currently ongoing, Australia grants priority review - - May 12, 2008
euro adhoc (Pressemitteilung),Institutes of Health (NIH) » Tuberculosis: TB vaccine formulated with adjuvant IC31® and developed in a partnership between Statens Serum Institut (SSI)
Background information on TB Vaccine [When available]
[an error occurred while processing this directive]
Search the web for more resources on TB Vaccine
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines
The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy